The Learning Center

CAR-T Therapy Across the World: Who Makes What and Who Pays Whom?

Description:

In Part 2 of our joint ASTCT-EBMT webinar, we will focus on cellular therapies such as chimeric antigen receptor T-cell (CAR-T) therapy across the world. Clinical and logistical landscapes for CAR-T therapies vary widely between countries: what therapies (if any), are available, how 'academic' or 'homegrown' CAR-T therapies are used, and how reimbursement is handled. We will also use case studies to highlight country-specific considerations with regard to logistics and infectious prophylaxis.

Learning Objectives:

1. To explore differences in how CAR-T therapies are regulated, implemented, and reimbursed in various countries around the world
2. To critically appraise emerging innovations in cell therapies, including “homegrown” non-commercial CAR-T constructs


Rahul Banerjee, MD, FACP

Rahul Banerjee, MD, FACP (Moderator)

University of Washington, Seattle

Nico Gagelmann, MD

Nico Gagelmann, MD (Moderator)

University Medical Center Hamburg-Eppendorf

Maximilan Merz, MD

Maximilan Merz, MD

Memorial Sloan Kettering Cancer Center

Tania Jain, MD

Tania Jain, MD

Johns Hopkins

Aina Oliver Caldés, MD

Aina Oliver Caldés, MD

Hospital Clínic Barcelona

Ana Cordeiro

Ana Cordeiro

A.C.Camargo Cancer Center

Key:

Complete
Failed
Available
Locked
CAR-T Therapy Across the World: Who Makes What and Who Pays Whom?
12/18/2025 at 9:00 AM (CST)  |  60 minutes
12/18/2025 at 9:00 AM (CST)  |  60 minutes
You must register to access.